Your browser doesn't support javascript.
loading
Imidazolium salts as an alternative for anti-Leishmania drugs: Oxidative and immunomodulatory activities.
Baldissera, Fernanda Giesel; Fazolo, Tiago; da Silva, Matheus Brasil; de Santana Filho, Paulo Cesar; da Silva, Vinícius Demétrio; Rivillo Perez, David Max; Klitzke, Joice Sandra; de Oliveira Soares, Eduardo Giovanni; Rodrigues Júnior, Luiz Carlos; Peres, Alessandra; Dallegrave, Eliane; Navegantes-Lima, Kely Campos; Monteiro, Marta Chagas; Schrekker, Henri Stephan; Torres Romão, Pedro Roosevelt.
Affiliation
  • Baldissera FG; Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • Fazolo T; Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • da Silva MB; Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • de Santana Filho PC; Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • da Silva VD; Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • Rivillo Perez DM; Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • Klitzke JS; Laboratory of Technological Processes and Catalysis, Institute of Chemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • de Oliveira Soares EG; Laboratory of Technological Processes and Catalysis, Institute of Chemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • Rodrigues Júnior LC; Laboratory of Technological Processes and Catalysis, Institute of Chemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • Peres A; Laboratory of Technological Processes and Catalysis, Institute of Chemistry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil.
  • Dallegrave E; Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • Navegantes-Lima KC; Graduate Program in Pharmaceutical Science, Graduate Program in Neuroscience and Cellular Biology, Faculty of Pharmacy, Universidade Federal do Pará, Belém, PA, Brazil.
  • Monteiro MC; Laboratory of Cellular and Molecular Immunology, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
  • Schrekker HS; Graduate Program in Pharmaceutical Science, Graduate Program in Neuroscience and Cellular Biology, Faculty of Pharmacy, Universidade Federal do Pará, Belém, PA, Brazil.
  • Torres Romão PR; Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
Front Immunol ; 13: 1096312, 2022.
Article in En | MEDLINE | ID: mdl-36733394
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmania mexicana / Leishmania infantum / Antiprotozoal Agents Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leishmania mexicana / Leishmania infantum / Antiprotozoal Agents Limits: Animals / Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article